UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Biology of Rickettsia rickettsii infection

Authors
Daniel J Sexton, MD
Micah T McClain, MD
Section Editors
Stephen B Calderwood, MD
Morven S Edwards, MD
Deputy Editor
Jennifer Mitty, MD, MPH

INTRODUCTION

Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever (RMSF) and the prototypic member of the genus Rickettsia. The basic biologic features of R. rickettsii and how it produces disease will be reviewed here. The clinical manifestations of RMSF and its treatment are discussed separately. (See "Clinical manifestations and diagnosis of Rocky Mountain spotted fever" and "Treatment of Rocky Mountain spotted fever".)

TAXONOMY

Like other gram-negative bacteria, R. rickettsii is a member of the alpha-group of purple bacteria. It is a member of the order Rickettsiales and the family Rickettsiaceae. The family Rickettsiaceae, in turn, contains the genera Rickettsia and Orientia. The genus Rickettsia is divided into the typhus and spotted fever groups.

R. rickettsii is the prototype of the spotted fever group, which has more than 12 separate pathogenic species (see "Other spotted fever group rickettsial infections"). Phylogenetic studies utilizing the 16S ribosome have shown that R. rickettsii is closely related to other members of the spotted fever group such as Rickettsia conorii and Rickettsia sibirica, whereas its phylogenetic relationship to other spotted fever members such as Rickettsia akari, Rickettsia australis, and Rickettsia belli is substantially more distant.

MICROBIOLOGY

R. rickettsii is a weakly gram-negative non-motile coccobacillus measuring 0.3 to 0.7 mcm by 0.8 to 2.0 mcm. R. rickettsii are difficult to see in tissue without special stains, but they can be visualized using Giemsa, Machiavello, and Gimenez staining and by the use of direct fluorescent antibody staining techniques.

Ultrastructure — R. rickettsii has ribosomes and a single circular chromosome located in an amorphous cytosol surrounded by a plasma membrane. In addition, an indistinct microcapsular layer is present on the outer surface of the cell wall. An electron-lucent zone separates this layer from the host cytosol. This zone is thought to represent a slime layer which may be important in pathogenicity [1].

          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Apr 25 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Walker DH. Rocky Mountain spotted fever: a disease in need of microbiological concern. Clin Microbiol Rev 1989; 2:227.
  2. Heinzen RA. Rickettsial actin-based motility: behavior and involvement of cytoskeletal regulators. Ann N Y Acad Sci 2003; 990:535.
  3. Winkler HH. Rickettsia species (as organisms). Annu Rev Microbiol 1990; 44:131.
  4. Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 1986; 35:840.
  5. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10:694.
  6. McDade JE. Evidence supporting the hypothesis that rickettsial virulence factors determine the severity of spotted fever and typhus group infections. Ann N Y Acad Sci 1990; 590:20.
  7. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 2005; 353:587.
  8. DuPont HL, Hornick RB, Dawkins AT, et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis 1973; 128:340.
  9. Gong W, Xiong X, Qi Y, et al. Identification of novel surface-exposed proteins of Rickettsia rickettsii by affinity purification and proteomics. PLoS One 2014; 9:e100253.
  10. Gong B, Shelite T, Mei FC, et al. Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A 2013; 110:19615.
  11. Walker DH. Targeting rickettsia. N Engl J Med 2006; 354:1418.
  12. Martinez JJ, Seveau S, Veiga E, et al. Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell 2005; 123:1013.
  13. Walker DH, Valbuena GA, Olano JP. Pathogenic mechanisms of diseases caused by Rickettsia. Ann N Y Acad Sci 2003; 990:1.
  14. Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis 2007; 45 Suppl 1:S39.
  15. Olano JP. Rickettsial infections. Ann N Y Acad Sci 2005; 1063:187.
  16. Walker DH, Olano JP, Feng HM. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infect Immun 2001; 69:1841.
  17. Hattwick MA, O'Brien RJ, Hanson BF. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med 1976; 84:732.
  18. Walker DH. The role of host factors in the severity of spotted fever and typhus rickettsioses. Ann N Y Acad Sci 1990; 590:10.
  19. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1118.